289 related articles for article (PubMed ID: 21468383)
1. Syk-kinase inhibition prevents mast cell activation in nasal polyps.
Patou J; Holtappels G; Affleck K; van Cauwenberge P; Bachert C
Rhinology; 2011 Mar; 49(1):100-6. PubMed ID: 21468383
[TBL] [Abstract][Full Text] [Related]
2. Identification of the Syk kinase inhibitor R112 by a human mast cell screen.
Rossi AB; Herlaar E; Braselmann S; Huynh S; Taylor V; Frances R; Issakani SD; Argade A; Singh R; Payan DG; Masuda ES
J Allergy Clin Immunol; 2006 Sep; 118(3):749-55. PubMed ID: 16950297
[TBL] [Abstract][Full Text] [Related]
3. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels.
Kepley CL
Int Arch Allergy Immunol; 2005 Sep; 138(1):29-39. PubMed ID: 16088210
[TBL] [Abstract][Full Text] [Related]
4. Characterization of syk expression in human lung mast cells: relationship with function.
Havard S; Scola AM; Kay LJ; Ishmael SS; MacGlashan DW; Peachell PT
Clin Exp Allergy; 2011 Mar; 41(3):378-88. PubMed ID: 21255137
[TBL] [Abstract][Full Text] [Related]
5. Homoisoflavanone prevents mast cell activation and allergic responses by inhibition of Syk signaling pathway.
Lee YS; Hur S; Kim TY
Allergy; 2014 Apr; 69(4):453-62. PubMed ID: 24446972
[TBL] [Abstract][Full Text] [Related]
6. NecroX-5 suppresses IgE/Ag-stimulated anaphylaxis and mast cell activation by regulating the SHP-1-Syk signaling module.
Li X; Kwon O; Kim DY; Taketomi Y; Murakami M; Chang HW
Allergy; 2016 Feb; 71(2):198-209. PubMed ID: 26456627
[TBL] [Abstract][Full Text] [Related]
7. ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of fcepsilon receptor I-mediated activation of Syk.
Moriya K; Rivera J; Odom S; Sakuma Y; Muramato K; Yoshiuchi T; Miyamoto M; Yamada K
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12539-44. PubMed ID: 9356485
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness.
Matsubara S; Li G; Takeda K; Loader JE; Pine P; Masuda ES; Miyahara N; Miyahara S; Lucas JJ; Dakhama A; Gelfand EW
Am J Respir Crit Care Med; 2006 Jan; 173(1):56-63. PubMed ID: 16192454
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constriction.
Moy LY; Jia Y; Caniga M; Lieber G; Gil M; Fernandez X; Sirkowski E; Miller R; Alexander JP; Lee HH; Shin JD; Ellis JM; Chen H; Wilhelm A; Yu H; Vincent S; Chapman RW; Kelly N; Hickey E; Abraham WM; Northrup A; Miller T; Houshyar H; Crackower MA
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1085-92. PubMed ID: 23889698
[TBL] [Abstract][Full Text] [Related]
10. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
11. Inducing an anergic state in mast cells and basophils without secretion.
MacGlashan D; Undem BJ
J Allergy Clin Immunol; 2008 Jun; 121(6):1500-6, 1506.e1-4. PubMed ID: 18539198
[TBL] [Abstract][Full Text] [Related]
12. Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue.
Patou J; Holtappels G; Affleck K; Gevaert P; Perez-Novo C; Van Cauwenberge P; Bachert C
J Inflamm (Lond); 2009 Apr; 6():11. PubMed ID: 19379488
[TBL] [Abstract][Full Text] [Related]
13. Syk kinase inhibitors in allergic diseases.
Denyer J; Patel V
Drug News Perspect; 2009 Apr; 22(3):146-50. PubMed ID: 19440557
[TBL] [Abstract][Full Text] [Related]
14. Camellia japonica suppresses immunoglobulin E-mediated allergic response by the inhibition of Syk kinase activation in mast cells.
Lee JH; Kim JW; Ko NY; Mun SH; Kim DK; Kim JD; Kim HS; Lee KR; Kim YK; Radinger M; Her E; Choi WS
Clin Exp Allergy; 2008 May; 38(5):794-804. PubMed ID: 18261158
[TBL] [Abstract][Full Text] [Related]
15. Mast cell activation is differentially affected by heat shock.
Mortaz E; Redegeld FA; van der Heijden MW; Wong HR; Nijkamp FP; Engels F
Exp Hematol; 2005 Aug; 33(8):944-52. PubMed ID: 16038788
[TBL] [Abstract][Full Text] [Related]
16. Syk inhibitors as treatment for allergic rhinitis.
Masuda ES; Schmitz J
Pulm Pharmacol Ther; 2008; 21(3):461-7. PubMed ID: 17669674
[TBL] [Abstract][Full Text] [Related]
17. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk.
Lee JH; Kim JW; Ko NY; Mun SH; Her E; Kim BK; Han JW; Lee HY; Beaven MA; Kim YM; Choi WS
J Allergy Clin Immunol; 2008 May; 121(5):1225-31. PubMed ID: 18394691
[TBL] [Abstract][Full Text] [Related]
18. The scaffold protein prohibitin is required for antigen-stimulated signaling in mast cells.
Kim DK; Kim HS; Kim AR; Jang GH; Kim HW; Park YH; Kim B; Park YM; Beaven MA; Kim YM; Choi WS
Sci Signal; 2013 Sep; 6(292):ra80. PubMed ID: 24023254
[TBL] [Abstract][Full Text] [Related]
19. A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally.
Mazuc E; Villoutreix BO; Malbec O; Roumier T; Fleury S; Leonetti JP; Dombrowicz D; Daëron M; Martineau P; Dariavach P
J Allergy Clin Immunol; 2008 Jul; 122(1):188-94, 194.e1-3. PubMed ID: 18539317
[TBL] [Abstract][Full Text] [Related]
20. 15,16-Dihydrotanshinone I suppresses IgE-Ag stimulated mouse bone marrow-derived mast cell activation by inhibiting Syk kinase.
Li X; Yang JH; Jin Y; Jin F; Kim DY; Chang JH; Kim JA; Son JK; Moon TC; Son KH; Chang HW
J Ethnopharmacol; 2015 Jul; 169():138-44. PubMed ID: 25917838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
